Figure 2.

Univariate survival analysis. (A) PR positive expression in patients with breast cancer was significantly associated with improved OS (P=0.028); (B) ER positive expression predicted prolonged OS in patients with breast cancer (P=0.006); (C) lymph nodes status had no statistical significance with the OS (P=0.217); (D) tumor size was significantly correlated with OS in our results (P=0.011); (E) there was no significance associated between HDAC3 expression and OS (P=0.653); (F) HDAC3 high expression predicted poor OS in patients with lymph nodes negative status (P=0.029).